Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joel L. Wherley currently holds 30,220 shares of CHEMED CORP (CHE), valued at approximately $0. This represents their equity stake as CEO - Vitas Healthcare.
Based on SEC Form 4 filings, Joel L. Wherley has been a net neutral trader of CHE stock. They have purchased $0 and sold $0 worth of shares.
Joel L. Wherley's most recent insider trade was on Aug 5, 2026, when they sold 2,599 shares at $445.35 per share.
Joel L. Wherley serves as CEO - Vitas Healthcare at CHEMED CORP (CHE). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Joel L. Wherley holds the position of CEO - Vitas Healthcare at CHEMED CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Joel L. Wherley has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Joel L. Wherley was on Aug 5, 2026, when they sold $1.2M worth of CHE shares. This transaction involved 2,270 shares at $542.62 per share.
Joel L. Wherley currently owns 30,220 shares of CHEMED CORP (CHE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joel L. Wherley's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joel L. Wherley has 3 Form 4 filings on record as an insider at CHEMED CORP.
Set alerts for Joel L. Wherley and 40,000+ other insiders.